Home » Newsletters » BioWorld

BioWorld

Aug. 19, 1993

View Archived Issues

CEPHALON INITIATES U.S. TRIALS OF MODAFINIL

ASSURANCES OF NO MANDATORY DRUG PRICE CONTROLS

HYBRIDON LICENSES ANTISENSE PATENTS

MITSUBISHI TO MARKET METAMOUSE IN JAPAN

COURT SUPPORTS REPLIGEN PATENT

PERSEPTIVE GETS IMMUNOASSAY PATENT

RESEARCH SUPPORTS MABS AS CANCER FIGHTERS

UNIVAX BEGINS VACCINE TRIALS

HARRIER RECEIVES NOTICE FOR PATENT

DDI BEGINS STUDIES ON ANTI-OXIDANTS

CELLPRO READY TO START TRIALS

NEW VERSION OF BIOSYS INSECTICIDE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...